IVF TREATMENT PRE- AND POST- THE ASRM COVID-19 PAUSE
| Autor: | Beth McAvey, Margaret Daneyko, Carlos Hernandez-Nieto, Christine Briton-Jones, Benjamin Sandler, Joseph A. Lee, E. Flisser, Alan B. Copperman, Daniel E. Stein, Tanmoy Mukherjee |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Assisted reproductive technology business.industry medicine.medical_treatment Obstetrics and Gynecology Retrospective cohort study Fertility clinic Article Patient safety Reproductive Medicine Health care Cohort Patient experience Emergency medicine Obstetrics and Gynaecology Medicine Anxiety medicine.symptom business |
| Zdroj: | Fertility and Sterility |
| ISSN: | 0015-0282 |
| DOI: | 10.1016/j.fertnstert.2020.08.512 |
| Popis: | Objective: The coronavirus (COVID-19) pandemic has forever reshaped the United States health care system However, assisted reproductive technology (ART) treatment remains an essential form of medicine Reproductive practices have since incorporated vigilant practices regarding social distancing, ample use of Personal Protective Equipment (PPE), and consistent decontamination protocols in order to mitigate risk of COVID-19 infection Altogether, changes to standard operating procedures within ART treatment centers are anticipated to support patient safety without compromising quality of reproductive care Finally, there is ample evidence of the mental health burden stemming from this pandemic with regard to anxiety and depression in both healthcare workers and patients Given the current uncertainty, our study evaluates IVF cycle outcome in a New York City patient cohort prior to and subsequent to the ASRM COVID-19 task force’s recommended treatment pause Design: Retrospective cohort analysis Materials and Methods: The study includes patients who underwent a single, euploid frozen-thawed embryo transfer (FET) from January 1st, 2020 to May 18th, 2020 Cohorts were separated into two groups based on period of IVF treatment (Group 1: Treatment prior to the COVID-19 pandemic pause;Group 2: Treatment subsequent to the COVID-19 pause) Primary outcome included early pregnancy rates Chi squared test was used and statistically significance was considered at p= |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|